Adiponectin, Leptin and Ghrelin Levels in Obese Adolescent Girls with Polycystic Ovary Syndrome

Journal of Pediatric and Adolescent Gynecology

Volumn 26, Issue 1, 2013, Pages 27-30

  Kale Gurbuz, Tugba ^a   Akhan, Suleyman Engin ^a   Bastu, Ercan ^a   Telci, Aysegul ^a   Iyibozkurt, Ahmet Cem ^a   Topuz, Samet ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Adiponectin; Ghrelin; Leptin; Obesity; Polycystic ovary syndrome

Indexed keywords

ADIPONECTIN; ESTRADIOL; FOLLITROPIN; GHRELIN; HYDROCORTISONE; LEPTIN; LUTEINIZING HORMONE; THYROTROPIN;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THYROTROPIN BLOOD LEVEL;

ADIPONECTIN; ADOLESCENT; CASE-CONTROL STUDIES; FEMALE; GHRELIN; HUMANS; LEPTIN; OBESITY; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84872500494     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2012.09.002     Document Type: Article

References (50)

1. Azziz R., Marin C., Hoq L., et al. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab 2005, 90:4650.
2. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997, 18:774.
3. Book C.B., Dunaif A. Selective insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 1999, 84:3110.
4. Berga S.L., Yen S.S. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1989, 30:177.
5. Christman G.M., Randolph J.F., Kelch R.P., et al. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease. J Clin Endocrinol Metab 1991, 72:1278.
6. Speroff L., Fritz M.A. Clinical Gynecologic Endocrinology and Infertility 2011, Lippincott Williams Wilkins, Philadelphia, pp 859-884. 8th ed.
7. Stamatakis E., Primatesta P., Chinn S., et al. Overweight and obesity trends from 1974 to 2003 in English children: what is the role of socioeconomic factors?. Arch Dis Child 2005, 90:999.
8. McCartney C.R., Prendergast K.A., Chhabra S., et al. Association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. J Clin Endocrinol Metab 2006, 91:1714.
9. Diamanti-Kandarakis E., Papailiou J., Palimeri S. Hyperandrogenemia: pathophysiology and its role in ovulatory dysfunction in PCOS. Pediatr Endocrinol Rev 2006, 3(Suppl 1):198.
10. Franks S., McCarthy M.I., Hardy K. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl 2006, 29:278.
11. Ibáñez L., Ferrer A., Ong K., et al. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome. J Pediatr 2004, 144:23.
12. Legro R.S. Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab 2002, 15(Suppl 5):1367.
13. Miner J.L. The adipocyte as an endocrine cell. J Anim Sci 2004, 82:935.
14. Mantzoros C.S. Role of leptin in reproduction. Ann N Y Acad Sci 2000, 900:174.
15. Spicer L.J. Leptin: a possible metabolic signal affecting reproduction. Domest Anim Endocrinol 2001, 21:251.
16. Meier U., Gressner A.M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004, 50:1511.
17. Gaytan F., Barreiro M.L., Chopin L.K., et al. Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary. J Clin Endocrinol Metab 2003, 88:879.
18. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
19. Ferriman D., Gallwey J.D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961, 21:1440.
20. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412.
21. Panidis D., Kourtis A., Farmakiotis D., et al. Serum adiponectin levels in women with polycystic ovary syndrome. Hum Reprod 2003, 18:1790.
22. Orio F., Palomba S., Zullo F., et al. Are serum adiponectin levels really reduced in obese women with polycystic ovary syndrome?. Hum Reprod 2004, 19:215.
23. Spranger J., Möhlig M., Wegewitz U., et al. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004, 61:738.
24. Pinhas-Hamiel O., Singer S., Pilpel N., et al. Adiponectin levels in adolescent girls with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2009, 71:823.
25. Yamauchi T., Kamon J., Minokoshi Y., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8:1288.
26. Svendsen P., Christiansen M., Hedley P.L., et al. Adipose expression of adipocytokines in women with polycystic ovary syndrome. Fertil Steril 2012, 98:235.
27. Mantzoros C.S., Dunaif A., Flier J.S. Leptin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 1997, 82:1687.
28. Chapman I.M., Wittert G.A., Norman R.J. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Clin Endocrinol (Oxf) 1997, 46:175.
29. Laughlin G.A., Morales A.J., Yen S.S. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. J Clin Endocrinol Metab 1997, 82:1692.
30. Rouru J., Anttila L., Koskinen P., et al. Leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997, 82:1697.
31. Lecke S.B., Mattei F., Morsch D.M., et al. Abdominal subcutaneous fat gene expression and circulation levels of leptin and adiponectin in polycystic ovary syndrome. Fertil Steril 2011, 95:2044.
32. Otukonyong E.E., Okutani F., Takahashi S., et al. Effect of food deprivation and leptin repletion on the plasma levels of estrogen (E2) and NADPH-d reactivity in the ventromedial and arcuate nuclei of the hypothalamus in the female rats. Brain Res 2000, 887:70.
33. Santini F., Galli G., Maffei M., et al. Acute exogenous TSH administration stimulates leptin secretion in vivo. Eur J Endocrinol 2010, 163:63.
34. Daghestani M.H., Daghestani M.H., El-Mazny A. Circulating ghrelin levels and the polycystic ovary syndrome: correlation with the clinical, hormonal and metabolic features. Eur J Obstet Gynecol Reprod Biol 2011, 155:65.
35. Glintborg D., Andersen M., Hagen C., et al. of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur J Endocrinol 2006, 155:337.
36. Micic D., Sumarac-Dumanovic M., Kendereski A., et al. Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome. J Endocrinol Invest 2007, 30:820.
37. Moran L.J., Noakes M., Clifton P.M., et al. Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome. Am J Clin Nutr 2007, 86:1603.
38. Barber T.M., Casanueva F.F., Karpe F., et al. levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome. Eur J Endocrinol 2008, 158:511.
39. Schofl C., Horn R., Schill T., et al. Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87:4607.
40. Orio F., Lucidi P., Palomba S., et al. Circulating ghrelin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 2003, 88:942.
41. Wasko R., Komarowska H., Warenik-Szymankiewicz A., et al. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome. Horm Metab Res 2004, 36:170.
42. Skommer J., Katulski K., Poreba E., et al. Ghrelin expression in women with polycystic ovary syndrome - a preliminary study. Eur J Gynaecol Oncol 2005, 26:553.
43. Komarowska H., Wasko R., Iwanik K., et al. Ovarian cell expression in patients with polycystic ovary syndrome: an immunohistochemical evaluation. Horm Metab Res 2006, 38:783.
44. Bik W., Baranowska-Bik A., Wolinska-Witort E., et al. The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome. Gynecol Endocrinol 2007, 23:325.
45. Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 2006, 91:786.
46. Bideci A., Camurdan M.O., Yesilkaya E., et al. Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome. J Obstet Gynaecol Res 2008, 34:578.
47. Broekmans F.J., Visser J.A., Laven J.S., et al. Anti-Müllerian hormone and ovarian dysfunction. Trends Endocrinol Metab 2008, 19:340.
48. Prelevic G.M., Würzburger M.I. Balint- Perić L: 24-hour serum cortisol profiles in women with polycystic ovary syndrome. Gynecol Endocrinol 1993, 7:179.
49. Stewart P.M., Shackleton C.H., Beastall G.H., et al. 5 alpha-reductase activity in polycystic ovary syndrome. Lancet 1990, 335(8687):431.
50. Roelfsema F., Kok P., Pereira A.M., et al. Cortisol production rate is similarly elevated in obese women with or without the polycystic ovary syndrome. J Clin Endocrinol Metab 2010, 95:3318.